Close Menu

NEW YORK (GenomeWeb) – Yourgene Health – formerly known as Premaitha Health – today reported a 45 percent increase in revenues for the first half of fiscal year 2018.

For the six months ended Sept. 30, the Manchester, UK-based noninvasive prenatal testing company reported £3.9 million ($5.0 million) in revenues compared to £2.7 million during the prior-year period. Revenues consisted of £2.5 million from products and £1.4 million from services.

Testing volumes during H1 increased 73 percent to 38,000 from 22,000 in H1 of FY2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.

Jun
13
Sponsored by
Roche

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19
Sponsored by
Roche

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.